Association Study of a Brain-Derived Neurotrophic-Factor Genetic Polymorphism and Major Depressive Disorders, Symptomatology, and Antidepressant Response

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 123 B, Issue 1, 2003, Pages 19-22

  Tsai, Shih Jen ^a,b   Cheng, Chih Ya ^a   Yu, Younger W Y ^c   Chen, Tai Jui ^d   Hong, Chen Jee ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Yu's Psychiatric Clinic   (Taiwan)

^d KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

Author keywords

Brain derived neurotrophic factor; Major depressive disorder; Polymorphism; Selective serotonin reuptake inhibitors; Treatment response

Indexed keywords

AMINO ACID; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; GENOMIC DNA; METHIONINE; SEROTONIN UPTAKE INHIBITOR; VALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0142219372     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20026     Document Type: Article

References (24)

1. Angelucci F, Aloe L, Vasquez PJ, Mathe AA. 2000. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport 11:1369-1373.
2. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265.
3. Duffy A, Grof P, Robertson C, Alda M. 2000. The implications of genetics studies of major mood disorders for clinical practice. J Clin Psychiatry 61:630-637.
4. Ernfors P, Kucera J, Lee KF, Loring J, Jaenisch R. 1995. Studies on the physiological role of brain-derived neurotrophic factor and neurotrophin-3 in knockout mice. Int J Dev Biol 39:799-807.
5. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
6. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. 1990. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9:2459-2464.
7. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. 2002. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148.
8. Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, Poirier MF, et al. 2000. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 5:558-562.
9. Lahiri DK, Nurnberger JI Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
10. Linnarsson S, Bjorklund A, Ernfors P. 1997. Learning deficit in BDNF mutant mice. Eur J Neurosci 9:2581-2587.
11. Maisonpierre PC, Le Beau MM, Espinosa R III, Ip NY, Belluscio L, de la Monte SM, et al. 1991. Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations. Genomics 10:558-568.
12. Momose Y, Murata M, Kobayashi K, Tachikawa M, Nakabayashi Y, Kanazawa I, et al. 2002. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 51:133-136.
13. Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, et al. 2000. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 36:197-202.
14. Murer MG, Yan Q, Raisman-Vozari R. 2001. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63:71-124.
15. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. 2001. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet 71:651-655.
16. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
17. Sapolsky RM, Uno H, Rebert CS, Finch CE. 1990. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10:2897-2902.
18. Serretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E. 1999. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry 4:280-283.
19. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. 1997. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137.
20. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. 1998. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511.
21. Smith MA, Makino S, Kvetnansky R, Post RM. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15:1768-1777.
22. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, et al. 2002. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 7:136-137.
23. Ward NL, Hagg T. 2000. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp Neurol 162:297-310.
24. Yu YWY, Tsai SJ, Chen TJ, Lin CH, Hong CJ. 2002. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7:1115-1119.